ResearcherAalborg University HospitalActive in the last 2 years
Susy Shim
Matched on ORCID iD 0000-0003-3248-4591; OpenAlex author ID A5118941394. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2023: 1 paper · 2024: none · 2025: 1 paper
Papers 2
- PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancr… Co-author DOI 10.1007/s10637-025-01526-7↗
- A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic c… Co-author DOI 10.1186/s12885-023-11035-6↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Morten Bækbo Ladekarl · 2 shared papers, 2023–2025 · strength 0.37
- Paper PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitax… DOI 10.1007/s10637-025-01526-7↗
- Paper A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable p… DOI 10.1186/s12885-023-11035-6↗
- Per Pfeiffer · 2 shared papers, 2023–2025 · strength 0.37
- Paper PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitax… DOI 10.1007/s10637-025-01526-7↗
- Paper A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable p… DOI 10.1186/s12885-023-11035-6↗
- Thomas Jens Ettrich · 1 shared paper, 2025 · strength 0.21
- Anke Reinacher‐Schick · 1 shared paper, 2025 · strength 0.21
- Angelika M. R. Kestler · 1 shared paper, 2025 · strength 0.21
- Louise S. Rasmussen · 1 shared paper, 2023 · strength 0.16
- Britta Weber · 1 shared paper, 2023 · strength 0.16
- Gabor Istvan Liposits · 1 shared paper, 2023 · strength 0.16
- Stine Brændegaard Winther · 1 shared paper, 2023 · strength 0.16
- Julia Sidenius Johansen · 1 shared paper, 2023 · strength 0.16
- Inna Markovna Chen · 1 shared paper, 2023 · strength 0.16
- Sönke Detlefsen · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.